Alvotech (NASDAQ:ALVOW – Get Free Report) was the target of a significant growth in short interest in January. As of January 30th, there was short interest totaling 1,428 shares, a growth of 32.7% from the January 15th total of 1,076 shares. Based on an average trading volume of 4,077 shares, the short-interest ratio is currently 0.4 days. Based on an average trading volume of 4,077 shares, the short-interest ratio is currently 0.4 days.
Alvotech Price Performance
Alvotech stock opened at $0.30 on Monday. Alvotech has a fifty-two week low of $0.23 and a fifty-two week high of $3.00. The firm’s 50 day simple moving average is $0.60 and its 200-day simple moving average is $0.99.
About Alvotech
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Read More
- Five stocks we like better than Alvotech
- This $15 Stock Could Go Down as the #1 Stock of 2026
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- Trump & Musk’s Secret Bet on Silver — Exposed
- Your Bank Account Is No Longer Safe
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
